1 Min Read
May 23 (Reuters) - BIOCARTIS GROUP NV:
* REG-BIOCARTIS GROUP NV: BIOCARTIS LAUNCHES CE-MARKED IVD NRAS TEST FOR COLORECTAL CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.